Optineurin Negatively Regulates TNFalpha- Induced NF-kappaB Activation by Competing with NEMO for Ubiquitinated RIP
Overview
Affiliations
NF-kappaB essential modulator (NEMO), the regulatory subunit of the IkappaB kinase (IKK) that activates NF-kappaB, is essential for NF-kappaB activation. NEMO was recently found to contain a region that preferentially binds Lys (K)63-linked but not K48-linked polyubiquitin (polyUb) chains, and the ability of NEMO to bind to K63-linked polyUb RIP (receptor-interacting protein) is necessary for efficient tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. Optineurin is a homolog of NEMO, and mutations in the optineurin gene are found in a subset of patients with glaucoma, a neurodegenerative disease involving the loss of retinal ganglion cells. Although optineurin shares considerable homology with NEMO, in resting cells, it is not present in the high-molecular-weight complex containing IKKalpha and IKKbeta, and optineurin cannot substitute for NEMO in lipopolysaccharide (LPS)-induced NF-kappaB activation. On the other hand, the overexpression of optineurin blocks the protective effect of E3-14.7K on cell death caused by the overexpression of TNFalpha receptor 1 (TNFR1). Here we show that optineurin has a K63-linked polyUb-binding region similar to that of NEMO, and like NEMO, it bound K63- but not K48-linked polyUb. Optineurin competitively antagonized NEMO's binding to polyUb RIP, and its overexpression inhibited TNFalpha-induced NF-kappaB activation. This competition occurs at physiologic protein levels because microRNA silencing of optineurin resulted in markedly enhanced TNFalpha-induced NF-kappaB activity. These results reveal a physiologic role for optineurin in dampening TNFalpha signaling, and this role might provide an explanation for its association with glaucoma.
The Seneca Valley virus 3C protease cleaves DCP1A to attenuate its antiviral effects.
Yang J, Li Z, Ma R, Xie S, Wang D, Quan R Vet Res. 2025; 56(1):46.
PMID: 40022242 PMC: 11869656. DOI: 10.1186/s13567-025-01477-0.
Wu C Cells. 2025; 14(4).
PMID: 39996775 PMC: 11854354. DOI: 10.3390/cells14040304.
LUBAC enables tumor-promoting LTβ receptor signaling by activating canonical NF-κB.
Chen Y, Rieser E, Bhamra A, Surinova S, Kreuzaler P, Ho M Cell Death Differ. 2024; 31(10):1267-1284.
PMID: 39215104 PMC: 11445442. DOI: 10.1038/s41418-024-01355-w.
Aberrant protein aggregation in amyotrophic lateral sclerosis.
Wang H, Zeng R J Neurol. 2024; 271(8):4826-4851.
PMID: 38869826 DOI: 10.1007/s00415-024-12485-z.
N4BP1 functions as a dimerization-dependent linear ubiquitin reader which regulates TNF signalling.
Kliza K, Song W, Pinzuti I, Schaubeck S, Kunzelmann S, Kuntin D Cell Death Discov. 2024; 10(1):183.
PMID: 38643192 PMC: 11032371. DOI: 10.1038/s41420-024-01913-8.